January 17, 2018 — An April 3 presentation during the 2017 Endocrine Society Annual Meeting and Expo featured an unpublished study abstract suggesting that low calorie sweeteners (LCS) increase adipogenesis in human fat biopsy-derived mesenchymal stromal cells (MSCs). Additionally, researchers suggest that LCS consumption also results in increased expression of glucose transporters, taste receptors, and adipogenic genes in subcutaneous fat of both normal weight and overweight adults. However, the research suffered from four drawbacks, as noted by the Calorie Control Council.
All LCS (including sucralose) that are present in the food supply, as well as in tabletop forms, have been extensively vetted and continuously receive approval by the leading regulatory and governmental agencies around the world, including the U.S. Food and Drug Administration (FDA) and the European Food Safety Authority (EFSA).
The post Research on Possible Impacts of Low Calorie Sweeteners on Glucose and Fat Are Not Based On Physiologically Relevant Data appeared first on Sucralose.